Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome: Association between endocrine characteristics and metabolic aberrations

Chu Chun Huang, Yin Jing Tien, Mei Jou Chen, Chun Houh Chen, Hong Nerng Ho, Yu Shih Yang

研究成果: 雜誌貢獻文章

12 引文 (Scopus)

摘要

Study Question What are the potential endocrine characteristics related to risk and severity of metabolic disturbances in women with polycystic ovary syndrome (PCOS)? Summary Answer Women with PCOS could be subtyped into four subgroups according to heterogeneous endocrine characteristics and the major predictive endocrine factors for metabolic aberrations among different subgroups were free androgen index (FAI) and luteinizing hormone (LH) levels. What is Known Already Women diagnosed with PCOS present with highly heterogeneous phenotypes, including endocrine and metabolic aberrations. Different strategies have been proposed to predict the metabolic outcomes but whether the endocrine factors can solely predict the metabolic aberrations is still inconclusive. Study Design, Size, Duration A cross-sectional study including 460 patients recruited from a reproductive endocrinology outpatient clinic of a tertiary medical center. Participants/Materials, Setting, Methods Patients with PCOS diagnosed according to the 2003 Rotterdam criteria were studied. Clinical history recorded by questionnaires, anthropometric measurements, biochemistry tests after an overnight fast, and pelvic ultrasonography were collected from all patients. Main Results and The Role of Chance Applying a matrix visualization and clustering approach (generalized association plots), the patients were divided into four distinct clusters according to the correlation with four endocrine parameters. Each cluster exhibited specific endocrine characteristics and the prevalence of metabolic syndrome (MS) was significantly different among the clusters (P < 0.0001). The high-risk subgroups for MS included one cluster with higher mean (SD) FAI (39.6 (14.7) in cluster 4), and another one with lower mean (SD) FAI (10 (6.4) in cluster 2). A common endocrine characteristic of these two metabolically unhealthy clusters was relatively lower LH level. Contrarily, higher LH level (â ‰§ 15 mIU/ml) during early follicular phase was found to be the best indicator of the metabolically healthy cluster (cluster 1). While high FAI level did correlate with more severe metabolic aberrations, high LH level showed better predictive value than low FAI level to become a metabolically healthy cluster. Limitations, Reasons For Caution The results should be applied to other populations with caution due to racial or environmental differences. Another limitation is a lack of normal non-PCOS control in our study. Wider Implications of The Findings Stratifying women with PCOS into meaningful subtypes could provide a better understanding of related risk factors and potentially enable the design and delivery of more effective screening and treatment intervention. Study Funding/Competing Interest(S) This study was supported by grant NSC 100-2314-B002-027-MY3 from the National Science Council of Taiwan. TRIAL REGISTRATION NUMBER Nil.
原文英語
頁(從 - 到)937-946
頁數10
期刊Human Reproduction
30
發行號4
DOIs
出版狀態已發佈 - 九月 30 2015
對外發佈Yes

指紋

Polycystic Ovary Syndrome
Androgens
Luteinizing Hormone
Follicular Phase
Organized Financing
Endocrinology
Ambulatory Care Facilities
Taiwan
Biochemistry
Cluster Analysis
Ovary
Ultrasonography
Cross-Sectional Studies
Phenotype
Population

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynaecology

引用此文

Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome : Association between endocrine characteristics and metabolic aberrations. / Huang, Chu Chun; Tien, Yin Jing; Chen, Mei Jou; Chen, Chun Houh; Ho, Hong Nerng; Yang, Yu Shih.

於: Human Reproduction, 卷 30, 編號 4, 30.09.2015, p. 937-946.

研究成果: 雜誌貢獻文章

Huang, Chu Chun ; Tien, Yin Jing ; Chen, Mei Jou ; Chen, Chun Houh ; Ho, Hong Nerng ; Yang, Yu Shih. / Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome : Association between endocrine characteristics and metabolic aberrations. 於: Human Reproduction. 2015 ; 卷 30, 編號 4. 頁 937-946.
@article{98f1b61c33334ee999ff4eda5fdbc11d,
title = "Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome: Association between endocrine characteristics and metabolic aberrations",
abstract = "Study Question What are the potential endocrine characteristics related to risk and severity of metabolic disturbances in women with polycystic ovary syndrome (PCOS)? Summary Answer Women with PCOS could be subtyped into four subgroups according to heterogeneous endocrine characteristics and the major predictive endocrine factors for metabolic aberrations among different subgroups were free androgen index (FAI) and luteinizing hormone (LH) levels. What is Known Already Women diagnosed with PCOS present with highly heterogeneous phenotypes, including endocrine and metabolic aberrations. Different strategies have been proposed to predict the metabolic outcomes but whether the endocrine factors can solely predict the metabolic aberrations is still inconclusive. Study Design, Size, Duration A cross-sectional study including 460 patients recruited from a reproductive endocrinology outpatient clinic of a tertiary medical center. Participants/Materials, Setting, Methods Patients with PCOS diagnosed according to the 2003 Rotterdam criteria were studied. Clinical history recorded by questionnaires, anthropometric measurements, biochemistry tests after an overnight fast, and pelvic ultrasonography were collected from all patients. Main Results and The Role of Chance Applying a matrix visualization and clustering approach (generalized association plots), the patients were divided into four distinct clusters according to the correlation with four endocrine parameters. Each cluster exhibited specific endocrine characteristics and the prevalence of metabolic syndrome (MS) was significantly different among the clusters (P < 0.0001). The high-risk subgroups for MS included one cluster with higher mean (SD) FAI (39.6 (14.7) in cluster 4), and another one with lower mean (SD) FAI (10 (6.4) in cluster 2). A common endocrine characteristic of these two metabolically unhealthy clusters was relatively lower LH level. Contrarily, higher LH level ({\^a} ‰§ 15 mIU/ml) during early follicular phase was found to be the best indicator of the metabolically healthy cluster (cluster 1). While high FAI level did correlate with more severe metabolic aberrations, high LH level showed better predictive value than low FAI level to become a metabolically healthy cluster. Limitations, Reasons For Caution The results should be applied to other populations with caution due to racial or environmental differences. Another limitation is a lack of normal non-PCOS control in our study. Wider Implications of The Findings Stratifying women with PCOS into meaningful subtypes could provide a better understanding of related risk factors and potentially enable the design and delivery of more effective screening and treatment intervention. Study Funding/Competing Interest(S) This study was supported by grant NSC 100-2314-B002-027-MY3 from the National Science Council of Taiwan. TRIAL REGISTRATION NUMBER Nil.",
keywords = "generalized association plots, metabolic syndrome, PCOS, SHBG",
author = "Huang, {Chu Chun} and Tien, {Yin Jing} and Chen, {Mei Jou} and Chen, {Chun Houh} and Ho, {Hong Nerng} and Yang, {Yu Shih}",
year = "2015",
month = "9",
day = "30",
doi = "10.1093/humrep/dev010",
language = "English",
volume = "30",
pages = "937--946",
journal = "Human Reproduction",
issn = "0268-1161",
publisher = "Oxford University Press",
number = "4",

}

TY - JOUR

T1 - Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome

T2 - Association between endocrine characteristics and metabolic aberrations

AU - Huang, Chu Chun

AU - Tien, Yin Jing

AU - Chen, Mei Jou

AU - Chen, Chun Houh

AU - Ho, Hong Nerng

AU - Yang, Yu Shih

PY - 2015/9/30

Y1 - 2015/9/30

N2 - Study Question What are the potential endocrine characteristics related to risk and severity of metabolic disturbances in women with polycystic ovary syndrome (PCOS)? Summary Answer Women with PCOS could be subtyped into four subgroups according to heterogeneous endocrine characteristics and the major predictive endocrine factors for metabolic aberrations among different subgroups were free androgen index (FAI) and luteinizing hormone (LH) levels. What is Known Already Women diagnosed with PCOS present with highly heterogeneous phenotypes, including endocrine and metabolic aberrations. Different strategies have been proposed to predict the metabolic outcomes but whether the endocrine factors can solely predict the metabolic aberrations is still inconclusive. Study Design, Size, Duration A cross-sectional study including 460 patients recruited from a reproductive endocrinology outpatient clinic of a tertiary medical center. Participants/Materials, Setting, Methods Patients with PCOS diagnosed according to the 2003 Rotterdam criteria were studied. Clinical history recorded by questionnaires, anthropometric measurements, biochemistry tests after an overnight fast, and pelvic ultrasonography were collected from all patients. Main Results and The Role of Chance Applying a matrix visualization and clustering approach (generalized association plots), the patients were divided into four distinct clusters according to the correlation with four endocrine parameters. Each cluster exhibited specific endocrine characteristics and the prevalence of metabolic syndrome (MS) was significantly different among the clusters (P < 0.0001). The high-risk subgroups for MS included one cluster with higher mean (SD) FAI (39.6 (14.7) in cluster 4), and another one with lower mean (SD) FAI (10 (6.4) in cluster 2). A common endocrine characteristic of these two metabolically unhealthy clusters was relatively lower LH level. Contrarily, higher LH level (â ‰§ 15 mIU/ml) during early follicular phase was found to be the best indicator of the metabolically healthy cluster (cluster 1). While high FAI level did correlate with more severe metabolic aberrations, high LH level showed better predictive value than low FAI level to become a metabolically healthy cluster. Limitations, Reasons For Caution The results should be applied to other populations with caution due to racial or environmental differences. Another limitation is a lack of normal non-PCOS control in our study. Wider Implications of The Findings Stratifying women with PCOS into meaningful subtypes could provide a better understanding of related risk factors and potentially enable the design and delivery of more effective screening and treatment intervention. Study Funding/Competing Interest(S) This study was supported by grant NSC 100-2314-B002-027-MY3 from the National Science Council of Taiwan. TRIAL REGISTRATION NUMBER Nil.

AB - Study Question What are the potential endocrine characteristics related to risk and severity of metabolic disturbances in women with polycystic ovary syndrome (PCOS)? Summary Answer Women with PCOS could be subtyped into four subgroups according to heterogeneous endocrine characteristics and the major predictive endocrine factors for metabolic aberrations among different subgroups were free androgen index (FAI) and luteinizing hormone (LH) levels. What is Known Already Women diagnosed with PCOS present with highly heterogeneous phenotypes, including endocrine and metabolic aberrations. Different strategies have been proposed to predict the metabolic outcomes but whether the endocrine factors can solely predict the metabolic aberrations is still inconclusive. Study Design, Size, Duration A cross-sectional study including 460 patients recruited from a reproductive endocrinology outpatient clinic of a tertiary medical center. Participants/Materials, Setting, Methods Patients with PCOS diagnosed according to the 2003 Rotterdam criteria were studied. Clinical history recorded by questionnaires, anthropometric measurements, biochemistry tests after an overnight fast, and pelvic ultrasonography were collected from all patients. Main Results and The Role of Chance Applying a matrix visualization and clustering approach (generalized association plots), the patients were divided into four distinct clusters according to the correlation with four endocrine parameters. Each cluster exhibited specific endocrine characteristics and the prevalence of metabolic syndrome (MS) was significantly different among the clusters (P < 0.0001). The high-risk subgroups for MS included one cluster with higher mean (SD) FAI (39.6 (14.7) in cluster 4), and another one with lower mean (SD) FAI (10 (6.4) in cluster 2). A common endocrine characteristic of these two metabolically unhealthy clusters was relatively lower LH level. Contrarily, higher LH level (â ‰§ 15 mIU/ml) during early follicular phase was found to be the best indicator of the metabolically healthy cluster (cluster 1). While high FAI level did correlate with more severe metabolic aberrations, high LH level showed better predictive value than low FAI level to become a metabolically healthy cluster. Limitations, Reasons For Caution The results should be applied to other populations with caution due to racial or environmental differences. Another limitation is a lack of normal non-PCOS control in our study. Wider Implications of The Findings Stratifying women with PCOS into meaningful subtypes could provide a better understanding of related risk factors and potentially enable the design and delivery of more effective screening and treatment intervention. Study Funding/Competing Interest(S) This study was supported by grant NSC 100-2314-B002-027-MY3 from the National Science Council of Taiwan. TRIAL REGISTRATION NUMBER Nil.

KW - generalized association plots

KW - metabolic syndrome

KW - PCOS

KW - SHBG

UR - http://www.scopus.com/inward/record.url?scp=84926615928&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926615928&partnerID=8YFLogxK

U2 - 10.1093/humrep/dev010

DO - 10.1093/humrep/dev010

M3 - Article

C2 - 25662806

AN - SCOPUS:84926615928

VL - 30

SP - 937

EP - 946

JO - Human Reproduction

JF - Human Reproduction

SN - 0268-1161

IS - 4

ER -